Stylianos Ivros

Metropolitan Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Stylianos Ivros is a surgical oncologist whose research focuses on minimally invasive approaches to gynecologic cancers, particularly endometrial cancer. His major contribution lies in advancing the evidence for sentinel lymph node biopsy (SLNB) as an alternative to systematic lymph node dissection in endometrial cancer staging. His 2023 study, “Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer,” retrospectively analyzed 41 patients to characterize the survival impact of SLNB—a critical gap in the literature. While this work has garnered 2 citations to date, it addresses a pressing clinical question: whether SLNB can safely reduce surgical morbidity without compromising oncologic outcomes. Dr. Ivros’s research bridges the gap between emerging robotic technologies and evidence-based practice, offering insights that could reshape surgical standards for endometrial cancer patients. His dedication to refining staging techniques underscores a commitment to improving both survival and quality of life in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Metropolitan Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago